Patent · US Active

Perineural administration of resiniferatoxin for treatment of maladaptive pain

US12144886B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 11, 2021
Grant dateNov 19, 2024
Priority date
Expiry dateDec 4, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods of administering resiniferatoxin (RTX) perineurally for treatment of maladaptive pain, and compositions for use in such methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.